| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Whitehawk Therapeutics, Inc. (WHWK) has 11 insiders with recent SEC Form 4 filings, including 21 buys and 0 sells. WHWK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 518.6K | $2.06M | -14,500 | |
| Other | 516.0K | $2.05M | -56,596 | |
| Other | 55.3K | $219.6K | - | |
| ? | 40.0K | $158.8K | - | |
| Dir | 40.0K | $158.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2018 | Satter Muneer A58 | Director, 10% Owner | Buy | 60,000 | $2.02 | $121,340.00 | +0.4% | |
| Dec 11, 2018 | Satter Muneer A58 | Director, 10% Owner | Buy | 60,000 | $2.12 | $127,242.00 | +0.4% | |
| Dec 6, 2018 | Satter Muneer A58 | Director, 10% Owner | Buy | 60,000 | $2.09 | $125,352.00 | +0.4% | |
| Nov 30, 2018 | Satter Muneer A58 | Director, 10% Owner | Buy | 60,000 | $1.98 | $118,524.00 | +0.4% | |
| Nov 12, 2018 | Hoffman Stephen J | Chief Executive Officer | Buy | 31,967 | $2.01 | $64,135.65 | +1,625% | |
| Jun 28, 2018 | Satter Muneer A58 | Director, 10% Owner | Buy | 1,818,182 | $3.85 | $7,000,000.70 | +55.8% | |
| Jun 28, 2018 | Khuong Chau Quang | Director, 10% Owner | Buy | 777,500 | $3.85 | $2,993,375.00 | +17.6% | |
| Jun 28, 2018 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 777,500 | $3.85 | $2,993,375.00 | +17.6% | |
| Mar 23, 2018 | Satter Muneer A58 | Director, 10% Owner | Buy | 5,000 | $4.88 | $24,390.00 | - | |
| Mar 20, 2018 | Satter Muneer A58 | Director, 10% Owner | Buy | 13,000 | $4.97 | $64,585.02 | +0.2% |